These biotech names are ripe for takeover: Cramer
August 27, 2013 at 19:19 PM EDT
We could be witnessing the beginning of a merger wave in biotech, where smaller firms are acquired by big drug companies looking for a new source of growth, Jim Cramer said Tuesday.